Bookimed does not add extra charges for Glioblastoma treatment prices. The rates come from the clinics' official price lists. You pay directly at the clinic for your treatment upon your arrival to the country.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Glioblastoma treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Glioblastoma treatment journey.
The cost of glioblastoma treatment can range from $10,450 to $18,040:
The doctor will determine the total treatment cost based on your needs and past treatments. You may not need to redo previous tests, which could save money.
| Italy | Turkey | Austria | |
| Resection of glioblastoma | - | from $16,000 | - |
| Gamma Knife | - | from $4,500 | - |
| Chemotherapy for breast cancer | - | from $1,200 | - |
Founded in 1969, Ospedale Santa Maria in Bari is accredited by the Italian Health Service with numerous first-class medical services. Born as a maternity clinic in the 1960s, the hospital still stands out today as the center of infertility treatment, prevention, diagnosis, and treatment of women's health. The hospital is home to the Breast Unit, a multidisciplinary unit dedicated to the prevention and treatment of breast cancer, which treats around 500 patients every year.
Professor Pietro Mortini MD is a highly experienced Italian neurosurgeon who specializes in neuro- and radiosurgeries with a focus on minimally invasive spine and brain operations. He is a Visiting Professor at the George Washington University, has a degree in Otorhinolaryngology and Neurosurgery from the University of Milan and University of Verona, and has patented a method of manufacturing a device for regenerating biological tissues. He also provides research in microsurgical therapy of pituitary adenomas and radiosurgery for uveal melanoma and is a member of the Italian Society of the Cranial Base.
Dr. Mohssen Ansarin is an oncologist specializing in head and neck cancer and is a funding member of SRS and AIOCC. He is an author and co-author of more than 50 articles, and is currently the Editor-in-Chief of ACTA Otolaryngologica.